Carson Wealth (CWM LLC)’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Buy |
9,403
+90
| +1% | +$2.15K | ﹤0.01% | 2068 |
|
|
2025
Q1 | $231K | Buy |
9,313
+16
| +0.2% | +$397 | ﹤0.01% | 1829 |
|
|
2024
Q4 | $175K | Buy |
9,297
+2,780
| +43% | +$52.3K | ﹤0.01% | 1910 |
|
|
2024
Q3 | $98K | Buy |
6,517
+5,716
| +714% | +$86K | ﹤0.01% | 2200 |
|
|
2024
Q2 | $23K | Sell |
801
-12
| -1% | -$345 | ﹤0.01% | 3027 |
|
|
2024
Q1 | $24K | Buy |
813
+51
| +7% | +$1.51K | ﹤0.01% | 2779 |
|
|
2023
Q4 | $26K | Sell |
762
-20
| -3% | -$682 | ﹤0.01% | 2599 |
|
|
2023
Q3 | $24K | Sell |
782
-672
| -46% | -$20.6K | ﹤0.01% | 2570 |
|
|
2023
Q2 | $58K | Buy |
1,454
+31
| +2% | +$1.24K | ﹤0.01% | 1874 |
|
|
2023
Q1 | $58K | Buy |
1,423
+980
| +221% | +$39.9K | ﹤0.01% | 1778 |
|
|
2022
Q4 | $17K | Buy |
443
+15
| +4% | +$576 | ﹤0.01% | 2482 |
|
|
2022
Q3 | $23K | Buy |
428
+100
| +30% | +$5.37K | ﹤0.01% | 2139 |
|
|
2022
Q2 | $19K | Sell |
328
-17
| -5% | -$985 | ﹤0.01% | 2149 |
|
|
2022
Q1 | $26K | Buy |
345
+30
| +10% | +$2.26K | ﹤0.01% | 1922 |
|
|
2021
Q4 | $19K | Buy |
+315
| New | +$19K | ﹤0.01% | 2023 |
|
|
2019
Q1 | – | Sell |
-9
| Closed | – | – | 3156 |
|
|
2018
Q4 | $0 | Buy |
+9
| New | – | ﹤0.01% | 2201 |
|